Chidamide-13C7

 化学構造式
1348337-81-4
CAS番号.
1348337-81-4
化学名:
别名:
英語名:
Chidamide-13C7
英語别名:
Chidamide-13C7;Azilsartan impurity W;Azilsartan Impurity 34;4'-(hydroxymethyl)biphenyl-2-carboxamide;2-methyl-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl);1H-Benzimidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-methyl-
CBNumber:
CB14808636
化学式:
C24H18N4O4
分子量:
426.42
MOL File:
1348337-81-4.mol

Chidamide-13C7 物理性質

比重(密度) :
1.42±0.1 g/cm3(Predicted)
酸解離定数(Pka):
2.01±0.10(Predicted)

安全性情報

Chidamide-13C7 価格

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入

Chidamide-13C7 化学特性,用途語,生産方法

Chidamide-13C7 上流と下流の製品情報

原材料

準備製品


Chidamide-13C7 生産企業

Global( 24)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
Standardpharm Co. Ltd.
86-714-3992388
overseasales1@yongstandards.com United States 14336 58
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
Artis Biotech Co. Ltd. 19138486554 18582380095
sales@artisbio.com China 3066 58
Shenzhen Botel Biotechnology Co. Ltd. 0755-22202135 13316968096
1979313431@qq.com China 7642 58
Guangzhou Dreampharm Biotechnology Co., Ltd. 17825480238
3008233717@qq.com China 9844 12
Hubei Moco Chemical Co., Ltd. 18627756402
3001051413@qq.com China 10009 58
Jinan blalong chemical co. LTD 2710913286@.com
1513643261@qq.com China 14253 58
Shanghai Lanc Pharmaceutical Technology Co., Ltd. 021-52216295 lankepharma
3813332848@qq.com China 436 58
Cato Research Chemicals Inc. 020-81215950 4000-868-328
customer@uwalab.com United States 10413 58
Taizhou Nanfeng Pharmaceutical Research Institute 12345678910
nanfengdrug@163.com China 15323 58

1348337-81-4()キーワード:


  • 1348337-81-4
  • Chidamide-13C7
  • Azilsartan Impurity 34
  • Azilsartan impurity W
  • 2-methyl-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)
  • 1H-Benzimidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-methyl-
  • 4'-(hydroxymethyl)biphenyl-2-carboxamide
Copyright 2017 © ChemicalBook. All rights reserved